- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
The Pneumococcal Test is a diagnostic tool used to detect the presence of Streptococcus pneumoniae, a bacterium that can cause a range of illnesses, including pneumonia, meningitis, and sepsis. The test is typically performed on a sample of blood, sputum, or cerebrospinal fluid, and can be used to diagnose an infection, determine the severity of the infection, and monitor the effectiveness of treatment.
The Pneumococcal Test market is a subset of the larger Diagnostics market, which includes a range of tests used to diagnose and monitor a variety of medical conditions. The Pneumococcal Test market is driven by the increasing prevalence of pneumococcal infections, as well as the need for accurate and timely diagnosis and treatment.
Some companies in the Pneumococcal Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, and Roche. Show Less Read more